Lifecore Biomedical, Inc. De (LFCR) Accumulated Expenses (2011 - 2025)

Lifecore Biomedical's Accumulated Expenses history runs 15 years deep, the most recent figure standing at $22.0 million for Q2 2025.

• In Q2 2025, Accumulated Expenses fell 2.57% year-over-year to $22.0 million; the TTM figure through May 2025 stood at $22.0 million (down 2.57% YoY), while the FY2025 annual figure was $22.0 million, down 2.57% from the prior year.
• Accumulated Expenses was $22.0 million for Q2 2025 at Lifecore Biomedical, up from $19.7 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $22.5 million in Q2 2024 to a low of $3.3 million in Q4 2021.
• Historically, Accumulated Expenses has averaged $8.2 million across 5 years, with a median of $5.7 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Accumulated Expenses plunged 53.64% in 2023, then jumped 443.74% in 2024.
• A 5-year view of Accumulated Expenses shows it stood at $3.3 million in 2021, then gained by 26.04% to $4.1 million in 2022, then dropped by 18.27% to $3.4 million in 2023, then soared by 38.07% to $4.6 million in 2024, then jumped by 374.15% to $22.0 million in 2025.
• The last three Accumulated Expenses figures came in at $22.0 million (Q2 2025), $19.7 million (Q1 2025), and $4.6 million (Q4 2024), per Business Quant data.